Home > Insider Trading > Filing (0000899243-17-019200)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1629137	Global Blood Therapeutics Inc.	GBT	Air Transportation, Scheduled (4512)	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1053466	L Deval Patrick	C/O Global Blood Therapeutics, Inc. 400 East Jamie Court, Suite 101 South San Francisco CA 94080		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-07-25	12,053	$3.40	12,053	No	4	M	Direct
Common Stock	Acquisiton	2017-07-25	15,000	$18.85	27,053	No	4	M	Direct
Common Stock	Disposition	2017-07-25	27,053	$29.69	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2017-07-25	12,053	$0.00	12,053	$3.40
Common Stock	Employee Stock Option (right to buy)	Disposition	2017-07-25	15,000	$0.00	15,000	$18.85

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
9,375		2025-04-08	No	4	M	Direct
0		2026-06-15	No	4	M	Direct

Footnotes

25% of the shares subject to this option vested and became exercisable on April 8, 2016, and the remaining shares subject to this option shall vest and become exercisable in 12 equal quarterly installments thereafter.
The shares vested and became exercisable in 12 equal monthly installments, with the first installment on July 16, 2016, subject to the recipient's continued service on the Issuer's Board of Directors. This option was subject to accelerated vesting upon a change of control of the Issuer.